Emerging Medication in Australia: A Potential Hope for Weight Loss ?
Australia is currently observing the arrival of retatrutide, a cutting-edge dual GIP and GLP-1 receptor agonist , representing a significant advance in addressing excess weight. Early clinical trials have demonstrated impressive results, showing greater impact than existing treatments like semagl